Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 04, 2023

BUY
$1.75 - $3.14 $1.75 Million - $3.14 Million
1,000,000 New
1,000,000 $1.75 Million
Q3 2022

Nov 03, 2022

SELL
$2.24 - $4.18 $76,160 - $142,120
-34,000 Reduced 96.59%
1,200 $4,000
Q1 2022

May 16, 2022

SELL
$5.7 - $9.3 $812,820 - $1.33 Million
-142,600 Reduced 80.2%
35,200 $266,000
Q3 2021

Nov 09, 2021

SELL
$13.52 - $23.95 $884,208 - $1.57 Million
-65,400 Reduced 26.89%
177,800 $2.47 Million
Q1 2021

May 13, 2021

SELL
$26.12 - $52.17 $7.34 Million - $14.7 Million
-281,100 Reduced 53.61%
243,200 $7.79 Million
Q4 2020

Feb 11, 2021

BUY
$14.05 - $29.0 $2.48 Million - $5.12 Million
176,700 Added 50.83%
524,300 $12.9 Million
Q3 2020

Nov 12, 2020

BUY
$14.17 - $19.48 $647,569 - $890,236
45,700 Added 15.14%
347,600 $4.98 Million
Q2 2020

Aug 12, 2020

SELL
$13.25 - $21.72 $7.34 Million - $12 Million
-554,100 Reduced 64.73%
301,900 $4.88 Million
Q1 2020

May 13, 2020

SELL
$9.73 - $24.9 $1.98 Million - $5.06 Million
-203,400 Reduced 19.2%
856,000 $12.3 Million
Q4 2019

Feb 10, 2020

BUY
$14.22 - $23.38 $2.7 Million - $4.44 Million
189,900 Added 21.84%
1,059,400 $22.3 Million
Q3 2019

Nov 14, 2019

BUY
$22.93 - $41.06 $1.05 Million - $1.87 Million
45,600 Added 5.53%
869,500 $19.9 Million
Q2 2019

Aug 14, 2019

SELL
$38.73 - $52.03 $3.76 Million - $5.05 Million
-97,000 Reduced 10.53%
823,900 $33.3 Million
Q1 2019

May 15, 2019

BUY
$28.11 - $50.77 $15.7 Million - $28.4 Million
559,800 Added 155.03%
920,900 $39.9 Million
Q4 2018

Feb 14, 2019

BUY
$26.22 - $56.89 $6.21 Million - $13.5 Million
236,800 Added 190.51%
361,100 $9.7 Million
Q3 2018

Nov 14, 2018

BUY
$24.31 - $52.74 $3.02 Million - $6.56 Million
124,300 New
124,300 $6.05 Million

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $1.32B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.